RxDoctor Payments Data

Jonathan Winograd, MD

Surgery of the Hand · Boston, MANPI 1982665485

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (39.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Integra Lifesciences Corporation at 51.6% of the total. Reporting peaked in 2024 at $3,948 and has fallen 75.2% since, to $979 in 2025.

$5,837in general payments, 2019–2025

Across 33 payments — averaging $176.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$3K
  • Axogen$2K
  • Derma Sciences, Inc.$136
  • Kls-martin L.p.$125
  • Mentor Worldwide LLC$104
  • Checkpoint Surgical, Inc$101
  • plus $103 from 3 others

What the payments were for

  • Travel & lodging$1,87932%
  • Food & beverage$1,65828%
  • Other$2,30039%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,837 in reported general payments places this provider in the 85th percentile of 23 surgery of the hand providers in Massachusetts.

See all surgery of the hand providers in Massachusetts

Medicare billing

Part B allowed, 2024
$103,099
Medicare patients
138
Services billed
387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery of the hand in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →